28
Participants
Start Date
February 12, 2021
Primary Completion Date
January 10, 2023
Study Completion Date
January 10, 2023
Mesenchymal Stromal Cells
Patients will be given the cell product by intravenous injection (into the vein through an IV line). Dose:1 x 10\^8 MSCs.
Supportive Care
Patients will receive supportive care per their treating physician
Houston Methodist Hospital, Houston
Center for Cell and Gene Therapy, Baylor College of Medicine
OTHER
The Methodist Hospital Research Institute
OTHER
Baylor College of Medicine
OTHER